利用家族史和基因检测确定结直肠癌风险
约35%的结直肠癌(CRC)患者有家族史,遗传因素与环境暴露均可能参与。仅5%–10%的CRC病例由高或中渗透率遗传变异导致,多数家族性CRC为无已知综合征的常见家族性CRC。二代测序推动基因检测从单综合征转向多基因同时检测,基于家族史和基因结果的个体化筛查可优化结肠镜使用以降低CRC发病率和死亡率。
要点
- 约35%的CRC患者有家族史,但仅5%–10%由高/中渗透率遗传变异所致。
- 多数家族性CRC和/或腺瘤家族不携带癌症综合征相关变异,属常见家族性CRC。
- 基因检测已从基于临床标准的单综合征检测转向多基因同时检测。
核心结论
- 基于家族癌症史和基因检测结果评估CRC风险,可实施个体化筛查与预防,优化结肠镜使用以有效降低CRC发病率和死亡率。
研究设计与样本
- 本文为综述,总结常见家族性CRC、CRC相关综合征(包括非息肉病型和息肉病型)的当前知识,并复习CRC筛查和监测建议及临床遗传评估与检测方法。
主要发现
- 约35%的CRC患者有家族史,归因于遗传因素、共同暴露或两者。
- 高或中渗透率遗传变异仅占CRC病例的5%至10%。
- 多数有CRC和/或腺瘤家族史的家庭不携带癌症综合征相关遗传变异,称为常见家族性CRC。
- 二代测序技术进展使对家族性CRC和癌症综合征的理解快速增加。
关键数值与推荐
- 高或中渗透率遗传变异仅占CRC病例的5%至10%。
- 约35%的CRC患者有家族史。
临床怎么用
- 临床实践中应基于家族癌症史和基因检测结果评估CRC风险。
- 采用个体化筛查和预防策略,优化结肠镜使用以降低CRC发病率和死亡率。
- 基因检测策略已从基于临床标准的特定遗传性癌症综合征检测转向多基因同时检测癌症相关变异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Approximately 35% of patients with colorectal cancer (CRC) have a family history of the disease attributed to genetic factors, common exposures, or both. Some families with a history of CRC carry genetic variants that cause CRC with high or moderate penetrance, but these account for only 5% to 10% of CRC cases. Most families with a history of CRC and/or adenomas do not carry genetic variants associated with cancer syndromes; this is called common familial CRC. Our understanding of familial predisposition to CRC and cancer syndromes has increased rapidly due to advances in next-generation sequencing technologies. As a result, there has been a shift from genetic testing for specific inherited cancer syndromes based on clinical criteria alone, to simultaneous testing of multiple genes for cancer-associated variants. We summarize current knowledge of common familial CRC, provide an update on syndromes associated with CRC (including the nonpolyposis and polyposis types), and review current recommendations for CRC screening and surveillance. We also provide an approach to genetic evaluation and testing in clinical practice. Determination of CRC risk based on family cancer history and results of genetic testing can provide a personalized approach to cancer screening and prevention, with optimal use of colonoscopy to effectively decrease CRC incidence and mortality.
引用
- Kastrinos F, Samadder NJ, Burt RW, et al. Use of Family History and Genetic Testing to Determine Risk of Colorectal Cancer. Gastroenterology. 2019. PMID: 31759928. doi:10.1053/j.gastro.2019.11.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。